|
|
|
| home > pmps > autumn 2021 > maintaining cold chain integrity for pharmaceutical products |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The social and economic implications of the
COVID-19 pandemic have been felt on a global scale. As millions of
people were forced into lockdown, hundreds of thousands of businesses
stalled their operations, while healthcare systems were pushed to
breaking point. The COVID-19 pandemic has impacted practically every
aspect of our lives and it has also greatly influenced the cold chain
logistics industry. Pharmaceutical transport hasn’t stopped, but rather
increased as patients suffering from COVID-19 and other illnesses
required tests and medications delivered at their clinic or home with
the right temperaturecontrolled solutions. Of course, the scale,
criticality, and urgency underpinning the global COVID-19 vaccine
roll-out has presented a unique challenge itself. The pandemic has
brought many new challenges together with demanding requirements to the
cold chain logistics industry, such as:
- Ultra-low temperatures required for storage and transport of the mRNA vaccines
- Increased
importance of last mile delivery – direct to patient, direct to
hospital, and direct to vaccination centres. Getting medication safely
to patients by shipping directly to vaccination centres, pharmacies, and
patient’s homes, while ensuring that products are delivered at the
right time and temperature
- Increased demand for dry ice, while vaccine manufacturers raced to develop and distribute COVID-19 vaccines worldwide
- Increased
demand on road transportation in the EU. Due to the fact that the
COVID-19 vaccines have required a specific range of temperatures for
storage and transport – together with the demand for dry ice
applications, limited capacity in air cargo, and end-to-end visibility
requirements across the EU – almost 90% of COVID-19 vaccines are
delivered by road freight
- Importance of real-time monitoring to reduce the risk of damage, loss of quality, and wastage of the high value medical products
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Muge Suner is Senior Pharma Business, Key-Strategic Accounts Manager for Thermo King in Europe, Middle East, and Africa. Based in Brussels, Belgium, she has been leading the Thermo King PharmaSolutions operations since 2019. Following her studies at the Ankara University in Turkey she began and continued her career in major forwarding and supply chain companies such as Cosco, DB Schenker, and DHL, where she was responsible for account management for temperature controlled solutions in life sciences, healthcare, and pharma.
|
|
|
|
|
|
 |
News and Press Releases |
 |
ACG appoints Udit K Singh as CEO of ACG Inspection
Mumbai 26 April, 2022: ACG, a leading supplier of fully
integrated manufacturing solutions to the global pharmaceutical and
nutraceutical industry, is pleased to announce the appointment of Mr.
Udit K Singh as the new chief executive officer (CEO) of its Inspection
Division.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: Summary of Year 2013
Synergy Research Group
Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials.
Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)
20-21 June 2022, Berlin, Germany
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is
held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers
pharmaceutical companies, CMOs and CDMOs, governmental bodies together
with pharmaceutical equipment providers and service companies to discuss
the manufacturing and packaging processes of the pharmaceutical
industry. Among the participating companies are Bayer, Sandoz, Merck,
Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >> |
|
|
